Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Sandu Pharmaceuticals has informed that the notice that Link in time India, the Registrar and Share Transfer Agent (RTA) of the Company has stopped Transfer on receipt of the request for Duplicate issue of Shares for the Shareholder. Details are attached.
The above information is a part of company’s filings submitted to BSE.